U.S. flag

An official website of the United States government

NM_012140.5(SLC25A10):c.304A>T (p.Lys102Ter) AND Mitochondrial DNA depletion syndrome 19

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Apr 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001251077.3

Allele description [Variation Report for NM_012140.5(SLC25A10):c.304A>T (p.Lys102Ter)]

NM_012140.5(SLC25A10):c.304A>T (p.Lys102Ter)

Gene:
SLC25A10:solute carrier family 25 member 10 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_012140.5(SLC25A10):c.304A>T (p.Lys102Ter)
HGVS:
  • NC_000017.11:g.81715568A>T
  • NM_001270888.2:c.304A>T
  • NM_001270953.2:c.304A>T
  • NM_012140.5:c.304A>TMANE SELECT
  • NP_001257817.1:p.Lys102Ter
  • NP_001257882.1:p.Lys102Ter
  • NP_036272.2:p.Lys102Ter
  • NC_000017.10:g.79682598A>T
  • NM_001270888.1:c.304A>T
Protein change:
K102*; LYS102TER
Links:
OMIM: 606794.0001; dbSNP: rs1555703272
NCBI 1000 Genomes Browser:
rs1555703272
Molecular consequence:
  • NM_001270888.2:c.304A>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001270953.2:c.304A>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_012140.5:c.304A>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Mitochondrial DNA depletion syndrome 19
Identifiers:
MONDO: MONDO:0033545; MedGen: C5436514; OMIM: 618972

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001426466OMIM
no assertion criteria provided
Pathogenic
(Nov 10, 2020)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001571204SIB Swiss Institute of Bioinformatics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 1, 2021)
unknowncuration

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedcuration
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency.

Punzi G, Porcelli V, Ruggiu M, Hossain MF, Menga A, Scarcia P, Castegna A, Gorgoglione R, Pierri CL, Laera L, Lasorsa FM, Paradies E, Pisano I, Marobbio CMT, Lamantea E, Ghezzi D, Tiranti V, Giannattasio S, Donati MA, Guerrini R, Palmieri L, Palmieri F, et al.

Hum Mol Genet. 2018 Feb 1;27(3):499-504. doi: 10.1093/hmg/ddx419.

PubMed [citation]
PMID:
29211846
PMCID:
PMC5886107

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV001426466.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a 9-year-old boy with mitochondrial DNA depletion syndrome-19 (MTDPS19; 618972), Punzi et al. (2018) identified compound heterozygous mutations in the SLC25A10 gene. The maternal allele carried a c.304A-T transversion (c.304A-T, NM_001270888.1), resulting in a lys102-to-ter (K102X) substitution, whereas the paternal allele carried 2 variants: a c.684C-T transition, resulting in a synonymous pro228-to-pro (P228P) substitution, and an intronic c.790-37G-A transition (606794.0002). The mutations were found by trio-based whole-exome sequencing. The K102X mutation was not found in the ExAC database. The c.684C-T transition had a frequency of 0.0014 and the splice site mutation a frequency of 0.0011 in the ExAC database. Patient fibroblasts showed a 10-fold decrease in SLC25A10 transcripts compared to controls. PCR analysis indicated that the L102X mutation likely resulted in nonsense-mediated mRNA decay, whereas both paternal mutations resulted in altered splicing. Western blot analysis did not detect the SLC25A10 protein. In vitro functional expression studies showed negligible, if any, transport activity for malate/phosphate exchange, consistent with a loss of function. In addition, patient cells showed a decrease in both the NADPH/NADP+ and GSH/GSSG ratios as well as a growth defect under stress conditions. Studies in yeast lacking the Slc25a10 ortholog showed impaired growth, impaired mitochondrial respiration, decreased mtDNA, and increased vulnerability to oxidative stress compared to controls.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From SIB Swiss Institute of Bioinformatics, SCV001571204.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)

Description

This variant is interpreted as a likely pathogenic for Mitochondrial DNA depletion syndrome 19, autosomal recessive. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Predicted nullvariant in a gene where LOF is a known mechanism of disease (PVS1 downgraded to moderate); Well-established functional studies show a deleterious effect (PS3 downgraded to moderate).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024